[Developing mechanism of the adverse effects of L-asparaginase and their control].
D000641:Ammonia / Q000097:blood; D001120:Arginine / Q000627:therapeutic use; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005971:Glutamates / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D009325:Nausea / Q000139:chemically induced; D006435:Renal Dialysis; D012640:Seizures / Q000139:chemically induced; D012769:Shock / Q000139:chemically induced; D014474:Unconsciousness / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D005971:Glutamates; D000641:Ammonia; D001120:Arginine; D001215:Asparaginase
Entstehungsmechanismus von L-Asparaginase-Nebenwirkungen und deren Bekämpfung.